Champions Oncology Non-GAAP EPS of $0.11 beats by $0.14, revenue of $14.06M beats by $0.83M

seekingalpha09-12

Champions Oncology press release (NASDAQ:CSBR): Q1 Non-GAAP EPS of $0.11 beats by $0.14. Revenue of $14.06M (+11.9% Y/Y) beats by $0.83M. The Company ended the quarter with cash on hand of ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466507192?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-12 04:36","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2466507192","market":"nz","top_or_hot":-1,"title":"Champions Oncology Non-GAAP EPS of $0.11 beats by $0.14, revenue of $14.06M beats by $0.83M","media":"seekingalpha","content":"<div>\n<p>Champions Oncology press release  (NASDAQ:CSBR): Q1  Non-GAAP EPS of $0.11  beats by $0.14.\nRevenue of $14.06M (+11.9% Y/Y)  beats by $0.83M.\nThe Company ended the quarter with cash on hand of ...</p>\n\n<a href=\"https://seekingalpha.com/news/4148812-champions-oncology-non-gaap-eps-of-0_11-beats-0_14-revenue-of-14_06m-beats-0_83m\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Champions Oncology Non-GAAP EPS of $0.11 beats by $0.14, revenue of $14.06M beats by $0.83M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChampions Oncology Non-GAAP EPS of $0.11 beats by $0.14, revenue of $14.06M beats by $0.83M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 04:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4148812-champions-oncology-non-gaap-eps-of-0_11-beats-0_14-revenue-of-14_06m-beats-0_83m><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Champions Oncology press release  (NASDAQ:CSBR): Q1  Non-GAAP EPS of $0.11  beats by $0.14.\nRevenue of $14.06M (+11.9% Y/Y)  beats by $0.83M.\nThe Company ended the quarter with cash on hand of ...</p>\n\n<a href=\"https://seekingalpha.com/news/4148812-champions-oncology-non-gaap-eps-of-0_11-beats-0_14-revenue-of-14_06m-beats-0_83m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSBR","symbol_name":"Champions Oncology, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4148812-champions-oncology-non-gaap-eps-of-0_11-beats-0_14-revenue-of-14_06m-beats-0_83m","article_id":"2466507192","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466507192","pubTimestamp":1726086976,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Champions Oncology press release  (NASDAQ:CSBR): Q1  Non-GAAP EPS of $0.11  beats by $0.14.\nRevenue of $14.06M (+11.9% Y/Y)  beats by $0.83M.\nThe Company ended the quarter with cash on hand of approximately $2.9 million. The Company has no debt.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CSBR":"Champions Oncology, Inc."},"translate_title":"Champions Oncology非GAAP每股收益为0.11美元超过预期为0.14美元，收入为1,406万美元超过预期为83万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSBR":1},"content_text":"Champions Oncology press release  (NASDAQ:CSBR): Q1  Non-GAAP EPS of $0.11  beats by $0.14.\nRevenue of $14.06M (+11.9% Y/Y)  beats by $0.83M.\nThe Company ended the quarter with cash on hand of approximately $2.9 million. The Company has no debt.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466507192"}